|
GRPEL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62725388719309E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.36521954536329E-12 |
| Normal-vs-Stage2 |
8.2237000542662E-09 |
| Normal-vs-Stage3 |
8.44999958893311E-10 |
| Normal-vs-Stage4 |
1.831740E-02 |
| Stage1-vs-Stage2 |
8.998400E-01 |
| Stage1-vs-Stage3 |
3.473200E-01 |
| Stage1-vs-Stage4 |
1.930000E-02 |
| Stage2-vs-Stage3 |
5.097000E-01 |
| Stage2-vs-Stage4 |
8.364000E-03 |
| Stage3-vs-Stage4 |
6.056300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73339120834726E-12 |
| Normal-vs-AfricanAmerican |
1.162514529085E-12 |
| Normal-vs-Asian |
1.207440E-01 |
| Caucasian-vs-AfricanAmerican |
7.938000E-01 |
| Caucasian-vs-Asian |
4.855800E-01 |
| AfricanAmerican-vs-Asian |
6.169600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99362748531939E-12 |
| Normal-vs-Female |
1.6269208202857E-12 |
| Male-vs-Female |
3.643800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.42752517876488E-12 |
| Normal-vs-Extreme_Weight |
2.98205904414317E-12 |
| Normal-vs-Obese |
9.00010066473556E-11 |
| Normal-vs-Extreme_Obese |
1.920490E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.589200E-01 |
| Normal_Weight-vs-Obese |
9.755200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.146150E-01 |
| Extreme_Weight-vs-Obese |
5.792800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.930040E-01 |
| Obese-vs-Extreme_Obese |
1.710210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.206100E-04 |
| Normal-vs-Age(41-60Yrs) |
2.76445533131664E-14 |
| Normal-vs-Age(61-80Yrs) |
1.22557519688371E-12 |
| Normal-vs-Age(81-100Yrs) |
8.56870000509602E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.487000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.477000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.107600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.977200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.040000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.660200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.14599999490039E-08 |
| Normal-VS-KIRP CIMP |
2.00299999997267E-06 |
| Normal-VS-Unclassified PRCC |
6.77479961019856E-10 |
| Type1 PRCC-VS-Type2 PRCC |
3.110200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.752000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.704600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.185800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.259800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.037800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.1002003448607E-10 |
| Normal-vs-N1 |
1.03600000000981E-06 |
| Normal-vs-N2 |
1.351070E-04 |
| N0-vs-N1 |
5.836800E-01 |
| N0-vs-N2 |
5.375000E-01 |
| N1-vs-N2 |
4.212400E-01 |
|
|
